Drug name - Abilify Maintena Kit
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8993761 | OTSUKA PHARM CO LTD | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
Sep, 2022
(a day ago) | |
| US8399469 | OTSUKA PHARM CO LTD | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
Jun, 2025
(2 years from now) | |
| CN1699346A | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Medicine And Preparation Method Thereof |
Dec, 2007
(14 years ago) | |
| CN101423493A | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug And Processes For Preparation Thereof |
Jun, 2012
(10 years ago) | |
| CN101574347B | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof |
Sep, 2019
(3 years ago) | |
| CN101434574A | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For Preparation Thereof |
Sep, 2019
(3 years ago) | |
| CN101423492A | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For Preparation Thereof |
Sep, 2019
(3 years ago) | |
| CN101579344A | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Medicine And Preparation Method Thereof |
Sep, 2019
(3 years ago) | |
| CN101579343B | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof |
Sep, 2019
(3 years ago) | |
| CN101579344B | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof |
Sep, 2019
(3 years ago) | |
| CN101579343A | OTSUKA PHARM CO LTD | Low-Hygroscopicity Aripiprazole Medicine And Preparation Method Thereof |
Sep, 2019
(3 years ago) | |
| CN101434573A | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For Preparation Thereof |
Sep, 2019
(3 years ago) | |
| CN101574347A | OTSUKA PHARM CO LTD | Low Hygroscopic Forms Of Aripiprazole And Preparation Method Thereof |
Sep, 2019
(3 years ago) | |
| CN101423492B | OTSUKA PHARM CO LTD | Aripiprazole Anhydride Crystal, Method For Producing The Same And Medicinal Preparation Containing The Same |
Sep, 2019
(3 years ago) | |
| CN103755632B | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof |
Sep, 2019
(3 years ago) | |
| CN101434574B | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof |
Sep, 2019
(3 years ago) | |
| CN101574348A | OTSUKA PHARM CO LTD | Aripiprazole With Low Hygroscopicity And Preparation Method Thereof |
Sep, 2019
(3 years ago) | |
| CN101434573B | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof |
Sep, 2019
(3 years ago) | |
| CN103755632A | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof |
Sep, 2019
(3 years ago) | |
| CN101574348B | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof |
Sep, 2019
(3 years ago) | |
| CN1817882A | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Medicine And Preparation Method Thereof |
Sep, 2022
(a day ago) | |
| CN103288727B | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof |
Sep, 2022
(a day ago) | |
| CN103288727A | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof |
Sep, 2022
(a day ago) | |
| CN1817882B | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof |
Sep, 2022
(a day ago) | |
| EP1330249A1 | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof |
Dec, 2020
(1 year, 9 months ago) | |
| EP1330249B1 | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof |
Dec, 2020
(1 year, 9 months ago) | |
| EP1419776A2 | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof |
Sep, 2022
(a day ago) | |
| EP1925308A1 | OTSUKA PHARM CO LTD | Pharmaceutical Solid Oral Aripiprazole Preparation And Processes For The Preparation Thereof |
Sep, 2022
(a day ago) | |
| EP1927357B1 | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole (Crystal E) Drug Substance And Processes For The Preparation Thereof |
Sep, 2022
(a day ago) | |
| EP1927355A1 | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole (Crystal F) Drug Substance And Processes For The Preparation Thereof |
Sep, 2022
(a day ago) | |
| EP1419776B1 | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof |
Sep, 2022
(a day ago) | |
| EP1925308B1 | OTSUKA PHARM CO LTD | Pharmaceutical Solid Oral Aripiprazole Preparation And Processes For The Preparation Thereof |
Sep, 2022
(a day ago) | |
| EP1419776B2 | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof |
Sep, 2022
(a day ago) | |
| EP1927357A3 | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole (Crystal E) Drug Substance And Processes For The Preparation Thereof |
Sep, 2022
(a day ago) | |
| EP1927355B1 | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole (Crystal F) Drug Substance And Processes For The Preparation Thereof |
Sep, 2022
(a day ago) | |
| EP1927356A1 | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole (Crystal D) Drug Substance And Processes For The Preparation Thereof |
Sep, 2022
(a day ago) | |
| EP1419776A9 | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof |
Sep, 2022
(a day ago) | |
| EP1927357A2 | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole (Crystal E) Drug Substance And Processes For The Preparation Thereof |
Sep, 2022
(a day ago) | |
| EP1927356B1 | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole (Crystal D) Drug Substance And Processes For The Preparation Thereof |
Sep, 2022
(a day ago) | |
| EP1419776A3 | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof |
Sep, 2022
(a day ago) | |
| EP1419776A8 | OTSUKA PHARM CO LTD | Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof |
Sep, 2022
(a day ago) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8759351 | OTSUKA PHARM CO LTD | Methods for administering aripiprazole |
Aug, 2023
(10 months from now) | |
| US8338428 | OTSUKA PHARM CO LTD | Methods for administering aripiprazole |
Aug, 2023
(10 months from now) | |
| US8030313 | OTSUKA PHARM CO LTD | Controlled release sterile injectable aripiprazole formulation and method |
Oct, 2024
(2 years from now) | |
| US7807680 | OTSUKA PHARM CO LTD | Controlled release sterile injectable aripiprazole formulation and method |
Oct, 2024
(2 years from now) | |
| US8722679 | OTSUKA PHARM CO LTD | Controlled release sterile injectable aripiprazole formulation and method |
Oct, 2024
(2 years from now) | |
| US8338427 | OTSUKA PHARM CO LTD | Methods for administering aripiprazole |
Mar, 2025
(2 years from now) | |
| US11154553 | OTSUKA PHARM CO LTD | Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function |
Sep, 2033
(11 years from now) | |
| US10980803 | OTSUKA PHARM CO LTD | Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function |
Sep, 2033
(11 years from now) | |
| US10525057 | OTSUKA PHARM CO LTD | Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function |
Mar, 2034
(11 years from now) | |
Drugs and Companies using ARIPIPRAZOLE ingredient
Treatment: Use of aripiprazole in extended release injectable suspension; use of aripiprazole in extended release injectable suspension in treating acute episodes of schizophrenia; Use of aripiprazole in extended release injectable suspension in treating acute episodes of schizophrenia; treatment of schizophrenia; Treatment of schizophrenia; treatment of schizophrenia, with efficacy in treating acute episodes of schizophrenia; Treatment of schizophrenia; use of aripiprazole in extended release injectable suspension in treating acute episodes of schizophrenia; Treatment of schizophrenia, with efficacy in treating acute episodes of schizophrenia; treatment of schizophrenia; maintenance monotherapy treatment of bipolar i disorder; Maintenance monotherapy treatment of bipolar 1 disorder; treatment of schizophrenia, with efficacy in treating acute episodes of schizophrenia; treatment of schizophrenia
Dosage: FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
| Strength | Dosage | Availability |
|---|---|---|
| 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | Prescription |
| 300MG | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | Prescription |
| 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | Prescription |
| 400MG | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.